Global Non-Oncology Precision Medicine Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Non-Oncology Precision Medicine market size was valued at US$ 81520 million in 2023. With growing demand in downstream market, the Non-Oncology Precision Medicine is forecast to a readjusted size of US$ 110640 million by 2030 with a CAGR of 4.5% during review period.
The research report highlights the growth potential of the global Non-Oncology Precision Medicine market. Non-Oncology Precision Medicine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Non-Oncology Precision Medicine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Non-Oncology Precision Medicine market.
In the non-oncology precision medicine market, the application of molecular biology is to study the etiology of diseases other than cancer at the molecular level, so target-based therapy or individualized therapy can be used to cure patients' health-related problems.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Non-Oncology Precision Medicine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Non-Oncology Precision Medicine market. It may include historical data, market segmentation by Type (e.g., Applied Sciences, Precision Diagnostics), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Non-Oncology Precision Medicine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Non-Oncology Precision Medicine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Non-Oncology Precision Medicine industry. This include advancements in Non-Oncology Precision Medicine technology, Non-Oncology Precision Medicine new entrants, Non-Oncology Precision Medicine new investment, and other innovations that are shaping the future of Non-Oncology Precision Medicine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Non-Oncology Precision Medicine market. It includes factors influencing customer ' purchasing decisions, preferences for Non-Oncology Precision Medicine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Non-Oncology Precision Medicine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Non-Oncology Precision Medicine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Non-Oncology Precision Medicine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Non-Oncology Precision Medicine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Non-Oncology Precision Medicine market.
Market Segmentation:
Non-Oncology Precision Medicine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Non-Oncology Precision Medicine market size was valued at US$ 81520 million in 2023. With growing demand in downstream market, the Non-Oncology Precision Medicine is forecast to a readjusted size of US$ 110640 million by 2030 with a CAGR of 4.5% during review period.
The research report highlights the growth potential of the global Non-Oncology Precision Medicine market. Non-Oncology Precision Medicine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Non-Oncology Precision Medicine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Non-Oncology Precision Medicine market.
In the non-oncology precision medicine market, the application of molecular biology is to study the etiology of diseases other than cancer at the molecular level, so target-based therapy or individualized therapy can be used to cure patients' health-related problems.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Non-Oncology Precision Medicine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Non-Oncology Precision Medicine market. It may include historical data, market segmentation by Type (e.g., Applied Sciences, Precision Diagnostics), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Non-Oncology Precision Medicine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Non-Oncology Precision Medicine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Non-Oncology Precision Medicine industry. This include advancements in Non-Oncology Precision Medicine technology, Non-Oncology Precision Medicine new entrants, Non-Oncology Precision Medicine new investment, and other innovations that are shaping the future of Non-Oncology Precision Medicine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Non-Oncology Precision Medicine market. It includes factors influencing customer ' purchasing decisions, preferences for Non-Oncology Precision Medicine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Non-Oncology Precision Medicine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Non-Oncology Precision Medicine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Non-Oncology Precision Medicine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Non-Oncology Precision Medicine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Non-Oncology Precision Medicine market.
Market Segmentation:
Non-Oncology Precision Medicine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Applied Sciences
- Precision Diagnostics
- Digital Health and Information Technology
- Precision Therapeutics
- Infectious Diseases
- Neurology
- Cardiovascular
- Lifestyle and Endocrinology
- Gastroenterology
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott Laboratories
- Agilent Technologies, Inc.
- Asuragen, Inc.
- Almac Group
- AstraZeneca PLC
- Bristol Myers Squibb
- bioMйrieux SA.
- BGI
- Danaher Corp.
- Illumina, Inc.
- Invitae Corporation
- Opko Health, Inc.
- Teva Pharmaceutical Industries Ltd.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-Oncology Precision Medicine Market Size 2019-2030
2.1.2 Non-Oncology Precision Medicine Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Non-Oncology Precision Medicine Segment by Type
2.2.1 Applied Sciences
2.2.2 Precision Diagnostics
2.2.3 Digital Health and Information Technology
2.2.4 Precision Therapeutics
2.3 Non-Oncology Precision Medicine Market Size by Type
2.3.1 Non-Oncology Precision Medicine Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Non-Oncology Precision Medicine Market Size Market Share by Type (2019-2024)
2.4 Non-Oncology Precision Medicine Segment by Application
2.4.1 Infectious Diseases
2.4.2 Neurology
2.4.3 Cardiovascular
2.4.4 Lifestyle and Endocrinology
2.4.5 Gastroenterology
2.4.6 Others
2.5 Non-Oncology Precision Medicine Market Size by Application
2.5.1 Non-Oncology Precision Medicine Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Non-Oncology Precision Medicine Market Size Market Share by Application (2019-2024)
3 NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE BY PLAYER
3.1 Non-Oncology Precision Medicine Market Size Market Share by Players
3.1.1 Global Non-Oncology Precision Medicine Revenue by Players (2019-2024)
3.1.2 Global Non-Oncology Precision Medicine Revenue Market Share by Players (2019-2024)
3.2 Global Non-Oncology Precision Medicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NON-ONCOLOGY PRECISION MEDICINE BY REGIONS
4.1 Non-Oncology Precision Medicine Market Size by Regions (2019-2024)
4.2 Americas Non-Oncology Precision Medicine Market Size Growth (2019-2024)
4.3 APAC Non-Oncology Precision Medicine Market Size Growth (2019-2024)
4.4 Europe Non-Oncology Precision Medicine Market Size Growth (2019-2024)
4.5 Middle East & Africa Non-Oncology Precision Medicine Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Non-Oncology Precision Medicine Market Size by Country (2019-2024)
5.2 Americas Non-Oncology Precision Medicine Market Size by Type (2019-2024)
5.3 Americas Non-Oncology Precision Medicine Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-Oncology Precision Medicine Market Size by Region (2019-2024)
6.2 APAC Non-Oncology Precision Medicine Market Size by Type (2019-2024)
6.3 APAC Non-Oncology Precision Medicine Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Non-Oncology Precision Medicine by Country (2019-2024)
7.2 Europe Non-Oncology Precision Medicine Market Size by Type (2019-2024)
7.3 Europe Non-Oncology Precision Medicine Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-Oncology Precision Medicine by Region (2019-2024)
8.2 Middle East & Africa Non-Oncology Precision Medicine Market Size by Type (2019-2024)
8.3 Middle East & Africa Non-Oncology Precision Medicine Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NON-ONCOLOGY PRECISION MEDICINE MARKET FORECAST
10.1 Global Non-Oncology Precision Medicine Forecast by Regions (2025-2030)
10.1.1 Global Non-Oncology Precision Medicine Forecast by Regions (2025-2030)
10.1.2 Americas Non-Oncology Precision Medicine Forecast
10.1.3 APAC Non-Oncology Precision Medicine Forecast
10.1.4 Europe Non-Oncology Precision Medicine Forecast
10.1.5 Middle East & Africa Non-Oncology Precision Medicine Forecast
10.2 Americas Non-Oncology Precision Medicine Forecast by Country (2025-2030)
10.2.1 United States Non-Oncology Precision Medicine Market Forecast
10.2.2 Canada Non-Oncology Precision Medicine Market Forecast
10.2.3 Mexico Non-Oncology Precision Medicine Market Forecast
10.2.4 Brazil Non-Oncology Precision Medicine Market Forecast
10.3 APAC Non-Oncology Precision Medicine Forecast by Region (2025-2030)
10.3.1 China Non-Oncology Precision Medicine Market Forecast
10.3.2 Japan Non-Oncology Precision Medicine Market Forecast
10.3.3 Korea Non-Oncology Precision Medicine Market Forecast
10.3.4 Southeast Asia Non-Oncology Precision Medicine Market Forecast
10.3.5 India Non-Oncology Precision Medicine Market Forecast
10.3.6 Australia Non-Oncology Precision Medicine Market Forecast
10.4 Europe Non-Oncology Precision Medicine Forecast by Country (2025-2030)
10.4.1 Germany Non-Oncology Precision Medicine Market Forecast
10.4.2 France Non-Oncology Precision Medicine Market Forecast
10.4.3 UK Non-Oncology Precision Medicine Market Forecast
10.4.4 Italy Non-Oncology Precision Medicine Market Forecast
10.4.5 Russia Non-Oncology Precision Medicine Market Forecast
10.5 Middle East & Africa Non-Oncology Precision Medicine Forecast by Region (2025-2030)
10.5.1 Egypt Non-Oncology Precision Medicine Market Forecast
10.5.2 South Africa Non-Oncology Precision Medicine Market Forecast
10.5.3 Israel Non-Oncology Precision Medicine Market Forecast
10.5.4 Turkey Non-Oncology Precision Medicine Market Forecast
10.5.5 GCC Countries Non-Oncology Precision Medicine Market Forecast
10.6 Global Non-Oncology Precision Medicine Forecast by Type (2025-2030)
10.7 Global Non-Oncology Precision Medicine Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Non-Oncology Precision Medicine Product Offered
11.1.3 Abbott Laboratories Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Agilent Technologies, Inc.
11.2.1 Agilent Technologies, Inc. Company Information
11.2.2 Agilent Technologies, Inc. Non-Oncology Precision Medicine Product Offered
11.2.3 Agilent Technologies, Inc. Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Agilent Technologies, Inc. Main Business Overview
11.2.5 Agilent Technologies, Inc. Latest Developments
11.3 Asuragen, Inc.
11.3.1 Asuragen, Inc. Company Information
11.3.2 Asuragen, Inc. Non-Oncology Precision Medicine Product Offered
11.3.3 Asuragen, Inc. Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Asuragen, Inc. Main Business Overview
11.3.5 Asuragen, Inc. Latest Developments
11.4 Almac Group
11.4.1 Almac Group Company Information
11.4.2 Almac Group Non-Oncology Precision Medicine Product Offered
11.4.3 Almac Group Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Almac Group Main Business Overview
11.4.5 Almac Group Latest Developments
11.5 AstraZeneca PLC
11.5.1 AstraZeneca PLC Company Information
11.5.2 AstraZeneca PLC Non-Oncology Precision Medicine Product Offered
11.5.3 AstraZeneca PLC Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 AstraZeneca PLC Main Business Overview
11.5.5 AstraZeneca PLC Latest Developments
11.6 Bristol Myers Squibb
11.6.1 Bristol Myers Squibb Company Information
11.6.2 Bristol Myers Squibb Non-Oncology Precision Medicine Product Offered
11.6.3 Bristol Myers Squibb Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Bristol Myers Squibb Main Business Overview
11.6.5 Bristol Myers Squibb Latest Developments
11.7 bioMйrieux SA.
11.7.1 bioMйrieux SA. Company Information
11.7.2 bioMйrieux SA. Non-Oncology Precision Medicine Product Offered
11.7.3 bioMйrieux SA. Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 bioMйrieux SA. Main Business Overview
11.7.5 bioMйrieux SA. Latest Developments
11.8 BGI
11.8.1 BGI Company Information
11.8.2 BGI Non-Oncology Precision Medicine Product Offered
11.8.3 BGI Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 BGI Main Business Overview
11.8.5 BGI Latest Developments
11.9 Danaher Corp.
11.9.1 Danaher Corp. Company Information
11.9.2 Danaher Corp. Non-Oncology Precision Medicine Product Offered
11.9.3 Danaher Corp. Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Danaher Corp. Main Business Overview
11.9.5 Danaher Corp. Latest Developments
11.10 Illumina, Inc.
11.10.1 Illumina, Inc. Company Information
11.10.2 Illumina, Inc. Non-Oncology Precision Medicine Product Offered
11.10.3 Illumina, Inc. Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Illumina, Inc. Main Business Overview
11.10.5 Illumina, Inc. Latest Developments
11.11 Invitae Corporation
11.11.1 Invitae Corporation Company Information
11.11.2 Invitae Corporation Non-Oncology Precision Medicine Product Offered
11.11.3 Invitae Corporation Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Invitae Corporation Main Business Overview
11.11.5 Invitae Corporation Latest Developments
11.12 Opko Health, Inc.
11.12.1 Opko Health, Inc. Company Information
11.12.2 Opko Health, Inc. Non-Oncology Precision Medicine Product Offered
11.12.3 Opko Health, Inc. Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Opko Health, Inc. Main Business Overview
11.12.5 Opko Health, Inc. Latest Developments
11.13 Teva Pharmaceutical Industries Ltd.
11.13.1 Teva Pharmaceutical Industries Ltd. Company Information
11.13.2 Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Product Offered
11.13.3 Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
11.13.5 Teva Pharmaceutical Industries Ltd. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-Oncology Precision Medicine Market Size 2019-2030
2.1.2 Non-Oncology Precision Medicine Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Non-Oncology Precision Medicine Segment by Type
2.2.1 Applied Sciences
2.2.2 Precision Diagnostics
2.2.3 Digital Health and Information Technology
2.2.4 Precision Therapeutics
2.3 Non-Oncology Precision Medicine Market Size by Type
2.3.1 Non-Oncology Precision Medicine Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Non-Oncology Precision Medicine Market Size Market Share by Type (2019-2024)
2.4 Non-Oncology Precision Medicine Segment by Application
2.4.1 Infectious Diseases
2.4.2 Neurology
2.4.3 Cardiovascular
2.4.4 Lifestyle and Endocrinology
2.4.5 Gastroenterology
2.4.6 Others
2.5 Non-Oncology Precision Medicine Market Size by Application
2.5.1 Non-Oncology Precision Medicine Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Non-Oncology Precision Medicine Market Size Market Share by Application (2019-2024)
3 NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE BY PLAYER
3.1 Non-Oncology Precision Medicine Market Size Market Share by Players
3.1.1 Global Non-Oncology Precision Medicine Revenue by Players (2019-2024)
3.1.2 Global Non-Oncology Precision Medicine Revenue Market Share by Players (2019-2024)
3.2 Global Non-Oncology Precision Medicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NON-ONCOLOGY PRECISION MEDICINE BY REGIONS
4.1 Non-Oncology Precision Medicine Market Size by Regions (2019-2024)
4.2 Americas Non-Oncology Precision Medicine Market Size Growth (2019-2024)
4.3 APAC Non-Oncology Precision Medicine Market Size Growth (2019-2024)
4.4 Europe Non-Oncology Precision Medicine Market Size Growth (2019-2024)
4.5 Middle East & Africa Non-Oncology Precision Medicine Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Non-Oncology Precision Medicine Market Size by Country (2019-2024)
5.2 Americas Non-Oncology Precision Medicine Market Size by Type (2019-2024)
5.3 Americas Non-Oncology Precision Medicine Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-Oncology Precision Medicine Market Size by Region (2019-2024)
6.2 APAC Non-Oncology Precision Medicine Market Size by Type (2019-2024)
6.3 APAC Non-Oncology Precision Medicine Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Non-Oncology Precision Medicine by Country (2019-2024)
7.2 Europe Non-Oncology Precision Medicine Market Size by Type (2019-2024)
7.3 Europe Non-Oncology Precision Medicine Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-Oncology Precision Medicine by Region (2019-2024)
8.2 Middle East & Africa Non-Oncology Precision Medicine Market Size by Type (2019-2024)
8.3 Middle East & Africa Non-Oncology Precision Medicine Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NON-ONCOLOGY PRECISION MEDICINE MARKET FORECAST
10.1 Global Non-Oncology Precision Medicine Forecast by Regions (2025-2030)
10.1.1 Global Non-Oncology Precision Medicine Forecast by Regions (2025-2030)
10.1.2 Americas Non-Oncology Precision Medicine Forecast
10.1.3 APAC Non-Oncology Precision Medicine Forecast
10.1.4 Europe Non-Oncology Precision Medicine Forecast
10.1.5 Middle East & Africa Non-Oncology Precision Medicine Forecast
10.2 Americas Non-Oncology Precision Medicine Forecast by Country (2025-2030)
10.2.1 United States Non-Oncology Precision Medicine Market Forecast
10.2.2 Canada Non-Oncology Precision Medicine Market Forecast
10.2.3 Mexico Non-Oncology Precision Medicine Market Forecast
10.2.4 Brazil Non-Oncology Precision Medicine Market Forecast
10.3 APAC Non-Oncology Precision Medicine Forecast by Region (2025-2030)
10.3.1 China Non-Oncology Precision Medicine Market Forecast
10.3.2 Japan Non-Oncology Precision Medicine Market Forecast
10.3.3 Korea Non-Oncology Precision Medicine Market Forecast
10.3.4 Southeast Asia Non-Oncology Precision Medicine Market Forecast
10.3.5 India Non-Oncology Precision Medicine Market Forecast
10.3.6 Australia Non-Oncology Precision Medicine Market Forecast
10.4 Europe Non-Oncology Precision Medicine Forecast by Country (2025-2030)
10.4.1 Germany Non-Oncology Precision Medicine Market Forecast
10.4.2 France Non-Oncology Precision Medicine Market Forecast
10.4.3 UK Non-Oncology Precision Medicine Market Forecast
10.4.4 Italy Non-Oncology Precision Medicine Market Forecast
10.4.5 Russia Non-Oncology Precision Medicine Market Forecast
10.5 Middle East & Africa Non-Oncology Precision Medicine Forecast by Region (2025-2030)
10.5.1 Egypt Non-Oncology Precision Medicine Market Forecast
10.5.2 South Africa Non-Oncology Precision Medicine Market Forecast
10.5.3 Israel Non-Oncology Precision Medicine Market Forecast
10.5.4 Turkey Non-Oncology Precision Medicine Market Forecast
10.5.5 GCC Countries Non-Oncology Precision Medicine Market Forecast
10.6 Global Non-Oncology Precision Medicine Forecast by Type (2025-2030)
10.7 Global Non-Oncology Precision Medicine Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Non-Oncology Precision Medicine Product Offered
11.1.3 Abbott Laboratories Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Agilent Technologies, Inc.
11.2.1 Agilent Technologies, Inc. Company Information
11.2.2 Agilent Technologies, Inc. Non-Oncology Precision Medicine Product Offered
11.2.3 Agilent Technologies, Inc. Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Agilent Technologies, Inc. Main Business Overview
11.2.5 Agilent Technologies, Inc. Latest Developments
11.3 Asuragen, Inc.
11.3.1 Asuragen, Inc. Company Information
11.3.2 Asuragen, Inc. Non-Oncology Precision Medicine Product Offered
11.3.3 Asuragen, Inc. Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Asuragen, Inc. Main Business Overview
11.3.5 Asuragen, Inc. Latest Developments
11.4 Almac Group
11.4.1 Almac Group Company Information
11.4.2 Almac Group Non-Oncology Precision Medicine Product Offered
11.4.3 Almac Group Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Almac Group Main Business Overview
11.4.5 Almac Group Latest Developments
11.5 AstraZeneca PLC
11.5.1 AstraZeneca PLC Company Information
11.5.2 AstraZeneca PLC Non-Oncology Precision Medicine Product Offered
11.5.3 AstraZeneca PLC Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 AstraZeneca PLC Main Business Overview
11.5.5 AstraZeneca PLC Latest Developments
11.6 Bristol Myers Squibb
11.6.1 Bristol Myers Squibb Company Information
11.6.2 Bristol Myers Squibb Non-Oncology Precision Medicine Product Offered
11.6.3 Bristol Myers Squibb Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Bristol Myers Squibb Main Business Overview
11.6.5 Bristol Myers Squibb Latest Developments
11.7 bioMйrieux SA.
11.7.1 bioMйrieux SA. Company Information
11.7.2 bioMйrieux SA. Non-Oncology Precision Medicine Product Offered
11.7.3 bioMйrieux SA. Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 bioMйrieux SA. Main Business Overview
11.7.5 bioMйrieux SA. Latest Developments
11.8 BGI
11.8.1 BGI Company Information
11.8.2 BGI Non-Oncology Precision Medicine Product Offered
11.8.3 BGI Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 BGI Main Business Overview
11.8.5 BGI Latest Developments
11.9 Danaher Corp.
11.9.1 Danaher Corp. Company Information
11.9.2 Danaher Corp. Non-Oncology Precision Medicine Product Offered
11.9.3 Danaher Corp. Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Danaher Corp. Main Business Overview
11.9.5 Danaher Corp. Latest Developments
11.10 Illumina, Inc.
11.10.1 Illumina, Inc. Company Information
11.10.2 Illumina, Inc. Non-Oncology Precision Medicine Product Offered
11.10.3 Illumina, Inc. Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Illumina, Inc. Main Business Overview
11.10.5 Illumina, Inc. Latest Developments
11.11 Invitae Corporation
11.11.1 Invitae Corporation Company Information
11.11.2 Invitae Corporation Non-Oncology Precision Medicine Product Offered
11.11.3 Invitae Corporation Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Invitae Corporation Main Business Overview
11.11.5 Invitae Corporation Latest Developments
11.12 Opko Health, Inc.
11.12.1 Opko Health, Inc. Company Information
11.12.2 Opko Health, Inc. Non-Oncology Precision Medicine Product Offered
11.12.3 Opko Health, Inc. Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Opko Health, Inc. Main Business Overview
11.12.5 Opko Health, Inc. Latest Developments
11.13 Teva Pharmaceutical Industries Ltd.
11.13.1 Teva Pharmaceutical Industries Ltd. Company Information
11.13.2 Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Product Offered
11.13.3 Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
11.13.5 Teva Pharmaceutical Industries Ltd. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Non-Oncology Precision Medicine Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Applied Sciences
Table 3. Major Players of Precision Diagnostics
Table 4. Major Players of Digital Health and Information Technology
Table 5. Major Players of Precision Therapeutics
Table 6. Non-Oncology Precision Medicine Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Non-Oncology Precision Medicine Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Non-Oncology Precision Medicine Market Size Market Share by Type (2019-2024)
Table 9. Non-Oncology Precision Medicine Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Non-Oncology Precision Medicine Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Non-Oncology Precision Medicine Market Size Market Share by Application (2019-2024)
Table 12. Global Non-Oncology Precision Medicine Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Non-Oncology Precision Medicine Revenue Market Share by Player (2019-2024)
Table 14. Non-Oncology Precision Medicine Key Players Head office and Products Offered
Table 15. Non-Oncology Precision Medicine Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Non-Oncology Precision Medicine Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Non-Oncology Precision Medicine Market Size Market Share by Regions (2019-2024)
Table 20. Global Non-Oncology Precision Medicine Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Non-Oncology Precision Medicine Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Non-Oncology Precision Medicine Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Non-Oncology Precision Medicine Market Size Market Share by Country (2019-2024)
Table 24. Americas Non-Oncology Precision Medicine Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Non-Oncology Precision Medicine Market Size Market Share by Type (2019-2024)
Table 26. Americas Non-Oncology Precision Medicine Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Non-Oncology Precision Medicine Market Size Market Share by Application (2019-2024)
Table 28. APAC Non-Oncology Precision Medicine Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Non-Oncology Precision Medicine Market Size Market Share by Region (2019-2024)
Table 30. APAC Non-Oncology Precision Medicine Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Non-Oncology Precision Medicine Market Size Market Share by Type (2019-2024)
Table 32. APAC Non-Oncology Precision Medicine Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Non-Oncology Precision Medicine Market Size Market Share by Application (2019-2024)
Table 34. Europe Non-Oncology Precision Medicine Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Non-Oncology Precision Medicine Market Size Market Share by Country (2019-2024)
Table 36. Europe Non-Oncology Precision Medicine Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Non-Oncology Precision Medicine Market Size Market Share by Type (2019-2024)
Table 38. Europe Non-Oncology Precision Medicine Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Non-Oncology Precision Medicine Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Non-Oncology Precision Medicine Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Non-Oncology Precision Medicine Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Non-Oncology Precision Medicine Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Non-Oncology Precision Medicine Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Non-Oncology Precision Medicine Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Non-Oncology Precision Medicine Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Non-Oncology Precision Medicine
Table 47. Key Market Challenges & Risks of Non-Oncology Precision Medicine
Table 48. Key Industry Trends of Non-Oncology Precision Medicine
Table 49. Global Non-Oncology Precision Medicine Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Non-Oncology Precision Medicine Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Non-Oncology Precision Medicine Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Non-Oncology Precision Medicine Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Abbott Laboratories Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 54. Abbott Laboratories Non-Oncology Precision Medicine Product Offered
Table 55. Abbott Laboratories Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Abbott Laboratories Main Business
Table 57. Abbott Laboratories Latest Developments
Table 58. Agilent Technologies, Inc. Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 59. Agilent Technologies, Inc. Non-Oncology Precision Medicine Product Offered
Table 60. Agilent Technologies, Inc. Main Business
Table 61. Agilent Technologies, Inc. Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Agilent Technologies, Inc. Latest Developments
Table 63. Asuragen, Inc. Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 64. Asuragen, Inc. Non-Oncology Precision Medicine Product Offered
Table 65. Asuragen, Inc. Main Business
Table 66. Asuragen, Inc. Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Asuragen, Inc. Latest Developments
Table 68. Almac Group Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 69. Almac Group Non-Oncology Precision Medicine Product Offered
Table 70. Almac Group Main Business
Table 71. Almac Group Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Almac Group Latest Developments
Table 73. AstraZeneca PLC Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 74. AstraZeneca PLC Non-Oncology Precision Medicine Product Offered
Table 75. AstraZeneca PLC Main Business
Table 76. AstraZeneca PLC Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. AstraZeneca PLC Latest Developments
Table 78. Bristol Myers Squibb Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 79. Bristol Myers Squibb Non-Oncology Precision Medicine Product Offered
Table 80. Bristol Myers Squibb Main Business
Table 81. Bristol Myers Squibb Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Bristol Myers Squibb Latest Developments
Table 83. bioMйrieux SA. Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 84. bioMйrieux SA. Non-Oncology Precision Medicine Product Offered
Table 85. bioMйrieux SA. Main Business
Table 86. bioMйrieux SA. Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. bioMйrieux SA. Latest Developments
Table 88. BGI Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 89. BGI Non-Oncology Precision Medicine Product Offered
Table 90. BGI Main Business
Table 91. BGI Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. BGI Latest Developments
Table 93. Danaher Corp. Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 94. Danaher Corp. Non-Oncology Precision Medicine Product Offered
Table 95. Danaher Corp. Main Business
Table 96. Danaher Corp. Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Danaher Corp. Latest Developments
Table 98. Illumina, Inc. Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 99. Illumina, Inc. Non-Oncology Precision Medicine Product Offered
Table 100. Illumina, Inc. Main Business
Table 101. Illumina, Inc. Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Illumina, Inc. Latest Developments
Table 103. Invitae Corporation Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 104. Invitae Corporation Non-Oncology Precision Medicine Product Offered
Table 105. Invitae Corporation Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Invitae Corporation Main Business
Table 107. Invitae Corporation Latest Developments
Table 108. Opko Health, Inc. Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 109. Opko Health, Inc. Non-Oncology Precision Medicine Product Offered
Table 110. Opko Health, Inc. Main Business
Table 111. Opko Health, Inc. Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. Opko Health, Inc. Latest Developments
Table 113. Teva Pharmaceutical Industries Ltd. Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 114. Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Product Offered
Table 115. Teva Pharmaceutical Industries Ltd. Main Business
Table 116. Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 117. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 1. Non-Oncology Precision Medicine Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Applied Sciences
Table 3. Major Players of Precision Diagnostics
Table 4. Major Players of Digital Health and Information Technology
Table 5. Major Players of Precision Therapeutics
Table 6. Non-Oncology Precision Medicine Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Non-Oncology Precision Medicine Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Non-Oncology Precision Medicine Market Size Market Share by Type (2019-2024)
Table 9. Non-Oncology Precision Medicine Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Non-Oncology Precision Medicine Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Non-Oncology Precision Medicine Market Size Market Share by Application (2019-2024)
Table 12. Global Non-Oncology Precision Medicine Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Non-Oncology Precision Medicine Revenue Market Share by Player (2019-2024)
Table 14. Non-Oncology Precision Medicine Key Players Head office and Products Offered
Table 15. Non-Oncology Precision Medicine Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Non-Oncology Precision Medicine Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Non-Oncology Precision Medicine Market Size Market Share by Regions (2019-2024)
Table 20. Global Non-Oncology Precision Medicine Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Non-Oncology Precision Medicine Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Non-Oncology Precision Medicine Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Non-Oncology Precision Medicine Market Size Market Share by Country (2019-2024)
Table 24. Americas Non-Oncology Precision Medicine Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Non-Oncology Precision Medicine Market Size Market Share by Type (2019-2024)
Table 26. Americas Non-Oncology Precision Medicine Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Non-Oncology Precision Medicine Market Size Market Share by Application (2019-2024)
Table 28. APAC Non-Oncology Precision Medicine Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Non-Oncology Precision Medicine Market Size Market Share by Region (2019-2024)
Table 30. APAC Non-Oncology Precision Medicine Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Non-Oncology Precision Medicine Market Size Market Share by Type (2019-2024)
Table 32. APAC Non-Oncology Precision Medicine Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Non-Oncology Precision Medicine Market Size Market Share by Application (2019-2024)
Table 34. Europe Non-Oncology Precision Medicine Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Non-Oncology Precision Medicine Market Size Market Share by Country (2019-2024)
Table 36. Europe Non-Oncology Precision Medicine Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Non-Oncology Precision Medicine Market Size Market Share by Type (2019-2024)
Table 38. Europe Non-Oncology Precision Medicine Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Non-Oncology Precision Medicine Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Non-Oncology Precision Medicine Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Non-Oncology Precision Medicine Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Non-Oncology Precision Medicine Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Non-Oncology Precision Medicine Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Non-Oncology Precision Medicine Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Non-Oncology Precision Medicine Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Non-Oncology Precision Medicine
Table 47. Key Market Challenges & Risks of Non-Oncology Precision Medicine
Table 48. Key Industry Trends of Non-Oncology Precision Medicine
Table 49. Global Non-Oncology Precision Medicine Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Non-Oncology Precision Medicine Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Non-Oncology Precision Medicine Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Non-Oncology Precision Medicine Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Abbott Laboratories Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 54. Abbott Laboratories Non-Oncology Precision Medicine Product Offered
Table 55. Abbott Laboratories Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Abbott Laboratories Main Business
Table 57. Abbott Laboratories Latest Developments
Table 58. Agilent Technologies, Inc. Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 59. Agilent Technologies, Inc. Non-Oncology Precision Medicine Product Offered
Table 60. Agilent Technologies, Inc. Main Business
Table 61. Agilent Technologies, Inc. Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Agilent Technologies, Inc. Latest Developments
Table 63. Asuragen, Inc. Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 64. Asuragen, Inc. Non-Oncology Precision Medicine Product Offered
Table 65. Asuragen, Inc. Main Business
Table 66. Asuragen, Inc. Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Asuragen, Inc. Latest Developments
Table 68. Almac Group Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 69. Almac Group Non-Oncology Precision Medicine Product Offered
Table 70. Almac Group Main Business
Table 71. Almac Group Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Almac Group Latest Developments
Table 73. AstraZeneca PLC Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 74. AstraZeneca PLC Non-Oncology Precision Medicine Product Offered
Table 75. AstraZeneca PLC Main Business
Table 76. AstraZeneca PLC Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. AstraZeneca PLC Latest Developments
Table 78. Bristol Myers Squibb Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 79. Bristol Myers Squibb Non-Oncology Precision Medicine Product Offered
Table 80. Bristol Myers Squibb Main Business
Table 81. Bristol Myers Squibb Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Bristol Myers Squibb Latest Developments
Table 83. bioMйrieux SA. Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 84. bioMйrieux SA. Non-Oncology Precision Medicine Product Offered
Table 85. bioMйrieux SA. Main Business
Table 86. bioMйrieux SA. Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. bioMйrieux SA. Latest Developments
Table 88. BGI Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 89. BGI Non-Oncology Precision Medicine Product Offered
Table 90. BGI Main Business
Table 91. BGI Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. BGI Latest Developments
Table 93. Danaher Corp. Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 94. Danaher Corp. Non-Oncology Precision Medicine Product Offered
Table 95. Danaher Corp. Main Business
Table 96. Danaher Corp. Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Danaher Corp. Latest Developments
Table 98. Illumina, Inc. Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 99. Illumina, Inc. Non-Oncology Precision Medicine Product Offered
Table 100. Illumina, Inc. Main Business
Table 101. Illumina, Inc. Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Illumina, Inc. Latest Developments
Table 103. Invitae Corporation Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 104. Invitae Corporation Non-Oncology Precision Medicine Product Offered
Table 105. Invitae Corporation Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Invitae Corporation Main Business
Table 107. Invitae Corporation Latest Developments
Table 108. Opko Health, Inc. Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 109. Opko Health, Inc. Non-Oncology Precision Medicine Product Offered
Table 110. Opko Health, Inc. Main Business
Table 111. Opko Health, Inc. Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. Opko Health, Inc. Latest Developments
Table 113. Teva Pharmaceutical Industries Ltd. Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 114. Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Product Offered
Table 115. Teva Pharmaceutical Industries Ltd. Main Business
Table 116. Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 117. Teva Pharmaceutical Industries Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Non-Oncology Precision Medicine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Non-Oncology Precision Medicine Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Non-Oncology Precision Medicine Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Non-Oncology Precision Medicine Sales Market Share by Country/Region (2023)
Figure 8. Non-Oncology Precision Medicine Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Non-Oncology Precision Medicine Market Size Market Share by Type in 2023
Figure 10. Non-Oncology Precision Medicine in Infectious Diseases
Figure 11. Global Non-Oncology Precision Medicine Market: Infectious Diseases (2019-2024) & ($ Millions)
Figure 12. Non-Oncology Precision Medicine in Neurology
Figure 13. Global Non-Oncology Precision Medicine Market: Neurology (2019-2024) & ($ Millions)
Figure 14. Non-Oncology Precision Medicine in Cardiovascular
Figure 15. Global Non-Oncology Precision Medicine Market: Cardiovascular (2019-2024) & ($ Millions)
Figure 16. Non-Oncology Precision Medicine in Lifestyle and Endocrinology
Figure 17. Global Non-Oncology Precision Medicine Market: Lifestyle and Endocrinology (2019-2024) & ($ Millions)
Figure 18. Non-Oncology Precision Medicine in Gastroenterology
Figure 19. Global Non-Oncology Precision Medicine Market: Gastroenterology (2019-2024) & ($ Millions)
Figure 20. Non-Oncology Precision Medicine in Others
Figure 21. Global Non-Oncology Precision Medicine Market: Others (2019-2024) & ($ Millions)
Figure 22. Global Non-Oncology Precision Medicine Market Size Market Share by Application in 2023
Figure 23. Global Non-Oncology Precision Medicine Revenue Market Share by Player in 2023
Figure 24. Global Non-Oncology Precision Medicine Market Size Market Share by Regions (2019-2024)
Figure 25. Americas Non-Oncology Precision Medicine Market Size 2019-2024 ($ Millions)
Figure 26. APAC Non-Oncology Precision Medicine Market Size 2019-2024 ($ Millions)
Figure 27. Europe Non-Oncology Precision Medicine Market Size 2019-2024 ($ Millions)
Figure 28. Middle East & Africa Non-Oncology Precision Medicine Market Size 2019-2024 ($ Millions)
Figure 29. Americas Non-Oncology Precision Medicine Value Market Share by Country in 2023
Figure 30. United States Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 31. Canada Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 32. Mexico Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 33. Brazil Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 34. APAC Non-Oncology Precision Medicine Market Size Market Share by Region in 2023
Figure 35. APAC Non-Oncology Precision Medicine Market Size Market Share by Type in 2023
Figure 36. APAC Non-Oncology Precision Medicine Market Size Market Share by Application in 2023
Figure 37. China Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 38. Japan Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 39. Korea Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 40. Southeast Asia Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 41. India Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 42. Australia Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 43. Europe Non-Oncology Precision Medicine Market Size Market Share by Country in 2023
Figure 44. Europe Non-Oncology Precision Medicine Market Size Market Share by Type (2019-2024)
Figure 45. Europe Non-Oncology Precision Medicine Market Size Market Share by Application (2019-2024)
Figure 46. Germany Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 47. France Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 48. UK Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 49. Italy Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 50. Russia Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 51. Middle East & Africa Non-Oncology Precision Medicine Market Size Market Share by Region (2019-2024)
Figure 52. Middle East & Africa Non-Oncology Precision Medicine Market Size Market Share by Type (2019-2024)
Figure 53. Middle East & Africa Non-Oncology Precision Medicine Market Size Market Share by Application (2019-2024)
Figure 54. Egypt Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 55. South Africa Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 56. Israel Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 57. Turkey Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 58. GCC Country Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 59. Americas Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 60. APAC Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 61. Europe Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 62. Middle East & Africa Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 63. United States Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 64. Canada Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 65. Mexico Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 66. Brazil Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 67. China Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 68. Japan Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 69. Korea Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 70. Southeast Asia Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 71. India Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 72. Australia Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 73. Germany Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 74. France Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 75. UK Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 76. Italy Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 77. Russia Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 78. Spain Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 79. Egypt Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 80. South Africa Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 81. Israel Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 82. Turkey Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 83. GCC Countries Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 84. Global Non-Oncology Precision Medicine Market Size Market Share Forecast by Type (2025-2030)
Figure 85. Global Non-Oncology Precision Medicine Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Non-Oncology Precision Medicine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Non-Oncology Precision Medicine Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Non-Oncology Precision Medicine Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Non-Oncology Precision Medicine Sales Market Share by Country/Region (2023)
Figure 8. Non-Oncology Precision Medicine Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Non-Oncology Precision Medicine Market Size Market Share by Type in 2023
Figure 10. Non-Oncology Precision Medicine in Infectious Diseases
Figure 11. Global Non-Oncology Precision Medicine Market: Infectious Diseases (2019-2024) & ($ Millions)
Figure 12. Non-Oncology Precision Medicine in Neurology
Figure 13. Global Non-Oncology Precision Medicine Market: Neurology (2019-2024) & ($ Millions)
Figure 14. Non-Oncology Precision Medicine in Cardiovascular
Figure 15. Global Non-Oncology Precision Medicine Market: Cardiovascular (2019-2024) & ($ Millions)
Figure 16. Non-Oncology Precision Medicine in Lifestyle and Endocrinology
Figure 17. Global Non-Oncology Precision Medicine Market: Lifestyle and Endocrinology (2019-2024) & ($ Millions)
Figure 18. Non-Oncology Precision Medicine in Gastroenterology
Figure 19. Global Non-Oncology Precision Medicine Market: Gastroenterology (2019-2024) & ($ Millions)
Figure 20. Non-Oncology Precision Medicine in Others
Figure 21. Global Non-Oncology Precision Medicine Market: Others (2019-2024) & ($ Millions)
Figure 22. Global Non-Oncology Precision Medicine Market Size Market Share by Application in 2023
Figure 23. Global Non-Oncology Precision Medicine Revenue Market Share by Player in 2023
Figure 24. Global Non-Oncology Precision Medicine Market Size Market Share by Regions (2019-2024)
Figure 25. Americas Non-Oncology Precision Medicine Market Size 2019-2024 ($ Millions)
Figure 26. APAC Non-Oncology Precision Medicine Market Size 2019-2024 ($ Millions)
Figure 27. Europe Non-Oncology Precision Medicine Market Size 2019-2024 ($ Millions)
Figure 28. Middle East & Africa Non-Oncology Precision Medicine Market Size 2019-2024 ($ Millions)
Figure 29. Americas Non-Oncology Precision Medicine Value Market Share by Country in 2023
Figure 30. United States Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 31. Canada Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 32. Mexico Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 33. Brazil Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 34. APAC Non-Oncology Precision Medicine Market Size Market Share by Region in 2023
Figure 35. APAC Non-Oncology Precision Medicine Market Size Market Share by Type in 2023
Figure 36. APAC Non-Oncology Precision Medicine Market Size Market Share by Application in 2023
Figure 37. China Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 38. Japan Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 39. Korea Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 40. Southeast Asia Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 41. India Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 42. Australia Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 43. Europe Non-Oncology Precision Medicine Market Size Market Share by Country in 2023
Figure 44. Europe Non-Oncology Precision Medicine Market Size Market Share by Type (2019-2024)
Figure 45. Europe Non-Oncology Precision Medicine Market Size Market Share by Application (2019-2024)
Figure 46. Germany Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 47. France Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 48. UK Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 49. Italy Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 50. Russia Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 51. Middle East & Africa Non-Oncology Precision Medicine Market Size Market Share by Region (2019-2024)
Figure 52. Middle East & Africa Non-Oncology Precision Medicine Market Size Market Share by Type (2019-2024)
Figure 53. Middle East & Africa Non-Oncology Precision Medicine Market Size Market Share by Application (2019-2024)
Figure 54. Egypt Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 55. South Africa Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 56. Israel Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 57. Turkey Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 58. GCC Country Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 59. Americas Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 60. APAC Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 61. Europe Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 62. Middle East & Africa Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 63. United States Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 64. Canada Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 65. Mexico Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 66. Brazil Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 67. China Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 68. Japan Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 69. Korea Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 70. Southeast Asia Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 71. India Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 72. Australia Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 73. Germany Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 74. France Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 75. UK Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 76. Italy Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 77. Russia Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 78. Spain Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 79. Egypt Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 80. South Africa Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 81. Israel Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 82. Turkey Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 83. GCC Countries Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 84. Global Non-Oncology Precision Medicine Market Size Market Share Forecast by Type (2025-2030)
Figure 85. Global Non-Oncology Precision Medicine Market Size Market Share Forecast by Application (2025-2030)
